Monday, October 8, 2018
Novo Nordisk initiated at Guggenheim
Novo Nordisk initiated with a Buy at Guggenheim. Guggenheim analyst Seamus Fernandez started Novo Nordisk with a Buy rating and DKK 361 price target, stating that he expects quality growth through 2020 and beyond ” as long as GLP-1 category price discipline remains.”
https://thefly.com/landingPageNews.php?id=2801217
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.